Scientists have shown in mice that skin cells re-programmed into brain stem cells, transplanted into the central nervous system, help reduce inflammation and may be able to help repair damage caused by multiple sclerosis (MS).
Our mouse study suggests that using a patient’s reprogrammed cells could provide a route to personalised treatment of chronic inflammatory diseases, including progressive forms of MS
The study, led by researchers at the University of Cambridge, is a step towards developing personalised treatments based on a patient’s own skin cells for diseases of the central nervous system (CNS).
In MS, the body’s own immune system attacks and damages myelin, the protective sheath around nerve fibres, causing disruption to messages sent around the brain and spinal cord. Symptoms are unpredictable and include problems with mobility and balance, pain, and severe fatigue.
Key immune cells involved in causing this damage are macrophages (literally ‘big eaters’), which ordinarily serve to attack and rid the body of unwanted intruders. A particular type of macrophage known as microglia are found throughout the brain and spinal cord – in progressive forms of MS, they attack the CNS, causing chronic inflammation and damage to nerve cells.
Recent advances have raised expectations that diseases of the CNS may be improved by the use of stem cell therapies. Stem cells are the body’s ‘master cells’, which can develop into almost any type of cell within the body. Previous work from the Cambridge team has shown that transplanting neural stem cells (NSCs) – stem cells that are part-way to developing into nerve cells – reduces inflammation and can help the injured CNS heal.
However, even if such a therapy could be developed, it would be hindered by the fact that such NSCs are sourced from embryos and therefore cannot be obtained in large enough quantities. Also, there is a risk that the body will see them as an alien invader, triggering an immune response to destroy them.
A possible solution to this problem would be the use of so-called ‘induced neural stem cells (iNSCs)’ – these cells can be generated by taking an adult’s skin cells and ‘re-programming’ them back to become neural stem cells. As these iNSCs would be the patient’s own, they are less likely to trigger an immune response.
Now, in research published in the journal Cell Stem Cell, researchers at the University of Cambridge have shown that iNSCs may be a viable option to repairing some of the damage caused by MS.
Using mice that had been manipulated to develop MS, the researchers discovered that chronic MS leads to significantly increased levels of succinate, a small metabolite that sends signals to macrophages and microglia, tricking them into causing inflammation, but only in cerebrospinal fluid, not in the peripheral blood.
Transplanting NSCs and iNSCs directly into the cerebrospinal fluid reduces the amount of succinate, reprogramming the macrophages and microglia – in essence, turning ‘bad’ immune cells ‘good’. This leads to a decrease in inflammation and subsequent secondary damage to the brain and spinal cord.
“Our mouse study suggests that using a patient’s reprogrammed cells could provide a route to personalised treatment of chronic inflammatory diseases, including progressive forms of MS,” says Dr Stefano Pluchino, lead author of the study from the Department of Clinical Neurosciences at the University of Cambridge.
“This is particularly promising as these cells should be more readily obtainable than conventional neural stem cells and would not carry the risk of an adverse immune response.”
The research team was led by Dr Pluchino, together with Dr Christian Frezza from the MRC Cancer Unit at the University of Cambridge, and brought together researchers from several university departments.
Dr Luca Peruzzotti-Jametti, the first author of the study and a Wellcome Trust Research Training Fellow, says: “We made this discovery by bringing together researchers from diverse fields including regenerative medicine, cancer, mitochondrial biology, inflammation and stroke and cellular reprogramming. Without this multidisciplinary collaboration, many of these insights would not have been possible.”
The Latest on: Personalised stem cell treatment
- Can-Fite Biopharma And Namodenoson In NAFLD/NASH: A Targeted Therapeutic Approach on November 13, 2018 at 6:01 am
A fascinating tailored/targeted approach worth emphasizing is the company’s technology platform of using A 3 receptor expression on cells as a ... Targeted therapy could be a unique model ... […]
- British research brings personalised treatment for blood cancer a step closer on November 13, 2018 at 5:57 am
Personalised treatments for leukaemia have come a step closer after a British study on the role gene mutations play in blood cancers. Scientists from the University of Birmingham analysed abnormal whi... […]
- DNAtrix and Valo Therapeutics Enter into Strategic Partnership to Develop Peptide-Coated Oncolytic Viruses for Treating Cancer on November 13, 2018 at 5:00 am
Given the ease with which this therapy can be adapted for emerging neoantigens, it has significant potential as a personalized therapeutic capable of focusing the immune system on generating cancer sp... […]
- Novocure Announces More than 70 Presentations on Tumor Treating Fields at 23rd Annual Meeting of the Society for Neuro-Oncology on November 13, 2018 at 4:24 am
(ATIM-31) Phase I Study of Tumor Treatment Fields and a Personalized Mutation-derived Tumor Vaccine ... Induces Replication Stress and Renders Tumor Cells Sensitive to Agents That Impinge upon These P... […]
- Research brings personalized medicine to treat leukemia one step closer on November 12, 2018 at 8:25 am
"Crucially, AML cells from patients with the same types of mutations ... which will see a different drug being given to treat each form of AML, creating personalised treatment for each cancer patient ... […]
- New Options and New Hope in Lung Cancer Treatment on November 9, 2018 at 12:53 am
Traditional approaches like chemotherapy and radiation attack and destroy cancer cells. Immune therapy works with the body’s own ... Qin: Another exciting frontier is personalized medicine — the abili... […]
- Inselspital offers a new form of therapy for leukemia and lymphoma on November 8, 2018 at 2:46 am
Urban Novak from the Inselspital. „The new therapy enables the patient’s immune cells to recognize and destroy tumor cells This takes us a step closer to a precise and truly personalized treatment.“ T... […]
- Exploring the Science, and the Snake Oil, Behind Regenerative Stem Cell Therapy on November 7, 2018 at 7:07 am
Stem cell therapy, Wolther continued ... He called the technology, which is still in the early stages of development, "the ultimate in personalized medicine." "If I remember correctly, this is from a ... […]
- Symposium to examine challenges in personalized medicine on November 7, 2018 at 2:20 am
"The molecular biology enabling personalized medicine has gone through incredible ... The eventʼs lectures will include topics such as the treatment of diabetes with stem cells, new methods available ... […]
- BriaCell Therapeutics Corp.’s CEO Talks Personalized Breast Cancer Treatment Technology with Uptick Newswire’s Stock Day Podcast on November 6, 2018 at 6:53 am
“BriaCell is developing the first off-the-shelf, personalized immunotherapy targeting ... against the cancer and not against normal cells,” Williams said. “So, we believe we have not only ... […]
via Google News and Bing News